To investigate the MEK and ERK expression and their relationship with clinicopathological parameters in human breast carcinoma, and the effect of preoperative chemotherapy on MEK and ERK protein expression.Samples were obtained from 56 patients with breast carcinoma and 8 patients with benign tumors. Sixteen of the 56 patients received preoperative chemotherapy. Western blot and immunohistochemistry were used to measure the expression of MEK1, MEK2 and ERK1, ERK2 protein.MEK2 and ERK1, ERK2 protein levels were increased in breast carcinoma tissue compared with those in adjacent normal tissues (t = 7.244, 5.959, 3.735, P < 0.01) and benign tumors (t = 2.206, P < 0.05). The levels of MEK1 were decreased. The expression of MEK2 protein i...
<p>(A) Western blot analysis to see the expression of p-MEK, MEK, p-Erk and Erk. MDA-MB 231 (left pa...
Mammalian cells express two closely related MEK isoforms, MEK1 and MEK2, upstream of the ERK1/ERK2 M...
<p>(A) 10 µg of normal/tumor-matched infiltrating ductal carcinoma (IDC) grades 1–3 and lymph node m...
To investigate the expression of extracellular signal-regulated kinase (ERK) and its relationship wi...
The extracellular-regulated kinase (ERK) 1/2 is one of the members of the mitogen-activated protein ...
<p>(A) Thirty nine human breast carcinoma tissue samples were stained with anti-p-ERK5 (Thr218/Tyr22...
To investigate the expression of mitogen-activated protein kinases (MAPKs) and its upstream protein ...
Background Mitogen-activated protein kinases (MAPKs) are signalling transduction molecules that have...
International audienceThe mitogen-activated protein kinases MEK/ERK pathway regulates fundamental pr...
<p>a: Non-Triple-negative Breast cancer; b: Triple-negative Breast cancer; c: lymph node.</p
AIM: To investigate the expression of mitogen-activated protein kinases (MAPKs) and its upstream pro...
with MEK1/2, pMEK1/2, ERK1/2 and pERK1/2. Phosphorylated forms of MEK1/2 and ERK1/2 are upregulated ...
<p>(A) Expression of ERα protein in human ovarian cancer cell lines. MCF-7, a breast cancer cell lin...
Objective(s) Curative treatment of breast cancer patients using chemotherapy often fails as a result...
Endocrine resistance and metastatic progression are primary causes of treatment failure in breast ca...
<p>(A) Western blot analysis to see the expression of p-MEK, MEK, p-Erk and Erk. MDA-MB 231 (left pa...
Mammalian cells express two closely related MEK isoforms, MEK1 and MEK2, upstream of the ERK1/ERK2 M...
<p>(A) 10 µg of normal/tumor-matched infiltrating ductal carcinoma (IDC) grades 1–3 and lymph node m...
To investigate the expression of extracellular signal-regulated kinase (ERK) and its relationship wi...
The extracellular-regulated kinase (ERK) 1/2 is one of the members of the mitogen-activated protein ...
<p>(A) Thirty nine human breast carcinoma tissue samples were stained with anti-p-ERK5 (Thr218/Tyr22...
To investigate the expression of mitogen-activated protein kinases (MAPKs) and its upstream protein ...
Background Mitogen-activated protein kinases (MAPKs) are signalling transduction molecules that have...
International audienceThe mitogen-activated protein kinases MEK/ERK pathway regulates fundamental pr...
<p>a: Non-Triple-negative Breast cancer; b: Triple-negative Breast cancer; c: lymph node.</p
AIM: To investigate the expression of mitogen-activated protein kinases (MAPKs) and its upstream pro...
with MEK1/2, pMEK1/2, ERK1/2 and pERK1/2. Phosphorylated forms of MEK1/2 and ERK1/2 are upregulated ...
<p>(A) Expression of ERα protein in human ovarian cancer cell lines. MCF-7, a breast cancer cell lin...
Objective(s) Curative treatment of breast cancer patients using chemotherapy often fails as a result...
Endocrine resistance and metastatic progression are primary causes of treatment failure in breast ca...
<p>(A) Western blot analysis to see the expression of p-MEK, MEK, p-Erk and Erk. MDA-MB 231 (left pa...
Mammalian cells express two closely related MEK isoforms, MEK1 and MEK2, upstream of the ERK1/ERK2 M...
<p>(A) 10 µg of normal/tumor-matched infiltrating ductal carcinoma (IDC) grades 1–3 and lymph node m...